Lv1
20 积分 2025-07-24 加入
SNP234, a novel potent, aggregate selective anti‐Aβ antibody, as next generation anti‐amyloid immunotherapy amicable for subcutaneous administration
2天前
已完结
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial
19天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
29天前
已完结
Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor
1个月前
已完结
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties
5个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
6个月前
已完结
皖公网安备34019202002308
